Skip to main content
logo
Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
22.35
-0.87 (-3.75%)
At close: Jan 13, 2026, 4:00 PM EST
22.50
+0.15 (0.67%)
After-hours: Jan 13, 2026, 7:59 PM EST

Catalyst Pharmaceuticals Market Cap

Catalyst Pharmaceuticals has a market cap or net worth of $2.75 billion as of January 13, 2026. Its market cap has increased by 5.12% in one year.

Market Cap
2.75B
Enterprise Value
2.06B
1-Year Change
5.12%
Ranking
#1810
Category
Mid-Cap
Stock Price
$22.35

Market Cap Chart

Since December 15, 2006, Catalyst Pharmaceuticals's market cap has increased from $69.00M to $2.75B, an increase of 3,881.29%. That is a compound annual growth rate of 21.28%.

History

DateMarket Cap% Change
Jan 13, 20262.75B-4.24%
Dec 31, 20252.87B15.25%
Dec 31, 20242.49B38.90%
Dec 29, 20231.79B-7.42%
Dec 30, 20221.94B177.28%
Dec 31, 2021698.10M101.65%
Dec 31, 2020346.20M-10.40%
Dec 31, 2019386.40M95.84%
Dec 31, 2018197.30M-40.80%
Dec 29, 2017333.30M283.10%
Dec 30, 201687.00M-57.12%
Dec 31, 2015202.90M-1.17%
Dec 31, 2014205.30M94.41%
Dec 31, 2013105.60M599.34%
Dec 31, 201215.10M-52.66%
Dec 30, 201131.90M66.15%
Dec 31, 201019.20M68.42%
Dec 31, 200911.40M-54.94%
Dec 31, 200825.30M-41.44%
Dec 31, 200743.20M-28.60%
Dec 29, 200660.50M-12.32%
Dec 15, 200669.00M-
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Eli Lilly and Company967.91B
Johnson & Johnson505.28B
AbbVie388.90B
UnitedHealth Group308.45B
AstraZeneca294.97B
Novartis AG274.30B
Merck & Co.271.01B
Novo Nordisk263.26B
Market Cap Rankings